FDA approves Roche’s new generation breast cancer-fighting drug
Called Kadcyla, the medication was reported to have minimal side effects in a clinical trial but will carry a warning label on the box
Continued here:
FDA approves Roche’s new generation breast cancer-fighting drug
Leave a Reply
You must be logged in to post a comment.
View video inside